Search

Search Results

Found 34 items.

Effects of the availability of new oral anticoagulants in patients with non-valvular atrial fibrillation in the real world: the NAIF study

Francesco Ventrella, Franco Mastroianni, Sergio Cappello, Luigi Iamele, Samantha Errico, Massimo Errico

176-183

06-07-2016

1417

PDF: 900

HTML: 341
Assessment and predictors of inappropriate dose of direct oral anticoagulants

Mosaad O. Almegren

09-01-2024

718

pdf: 347

HTML: 112
Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation

Tommaso Sacquegna, Anna Zaniboni, Andrea Rubboli, Gaetano Procaccianti, Michela Crisci, Fabiola Maioli, Giorgia Arnone, Giuseppe Di Pasquale

314-322

15-12-2015

1914

PDF: 881

HTML: 1227
The practical management of bleedings during treatment with direct oral anticoagulants: the emergency reversal therapy

Luca Masotti, Giancarlo Landini, Grazia Panigada

48-58

24-12-2013

1322

PDF: 900
Pharmacology of new oral anticoagulants: mechanism of action, pharmacokinetics, pharmacodynamics

Luca Masotti, Mauro Campanini

1-7

24-12-2013

9472

PDF: 2668
Direct oral anticoagulants in real practice: which doses for which patients. Limitations and bleeding risk compared to vitamin K antagonists

Giancarlo Landini, Luca Masotti

41-47

24-12-2013

881

PDF: 773
Direct oral anticoagulants for secondary prevention in patients with non-valvular atrial fibrillation

Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Cecilia Becattini, Maurizio Paciaroni, Daniel Augustin Godoy, Roberto Cappelli, Giancarlo Landini, Grazia Panigada, Ido Iori, Domenico Prisco, Giancarlo Agnelli

8-21

24-12-2013

1271

PDF: 835
A review on management of antiphospholipid syndrome in clinical practice

Carmine Siniscalchi, Pietro Rossetti, Gaetano Carolla, Pierpaolo Di Micco, Adriano Stella, Michele Riva

13-09-2023

2143

PDF: 899

HTML: 53
Vorapaxar

Gianluca Airoldi, Mauro Campanini

88-95

24-04-2013

1124

PDF: 619

HTML: 219
Newer non-vitamin K-antagonist direct oral anticoagulants in acute coronary syndromes

Andrea Rubboli

22-28

24-12-2013

952

PDF: 714
Apixaban

Gianluca Airoldi, Mauro Campanini

128-134

07-03-2013

1104

PDF: 1760
New oral anticoagulants: key messages for clinicians

Matteo Giorgi-Pierfranceschi, Chiara Cattabiani, Francesco Dentali

74-84

24-12-2013

1236

PDF: 844
Efficacy and safety of new oral anticoagulants compared with warfarin in cardioembolic prophylaxis of patients with non valvular atrial fibrillation. More lights than shadows

Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Daniel Godoy, Grazia Panigada, NiccolÃ² Napoli, Giancarlo Landini, Roberto Cappelli, Ido Iori, Domenico Prisco, Giancarlo Agnelli

153-169

23-10-2012

1625

PDF: 1924
Cryptogenic stroke

Michele Stornello, Roberto Cappellani, Giuseppe Micieli, Simona Sacco, Stefano Spolveri, Roberto Sterzi, Danilo Toni, Antonio Carolei

185-194

30-09-2016

1830

PDF: 1070

HTML: 581
Pregnancy and heart disease: what Internists should know

Riccardo Gerloni, Domenico Panuccio

288-304

11-09-2017

1263

PDF: 638

HTML: 263
Acute severe renal failure in a patient receiving apixaban: a case report

Attilia Maria Pizzini, Chiara Fantoni, Stefania Zaccaroni, Mauro Silingardi

09-04-2024

419

PDF: 326

HTML: 67
Stroke prevention in atrial fibrillation: findings from Tuscan FADOI Stroke Registry

Luca Masotti, Rinaldo Innocenti, Stefano Spolveri, Irene Chiti, Grazia Panigada, Cristiana Seravalle, Giancarlo Landini, Alberto Fortini, Rino Migliacci, Raffaele Laureano, for Tuscan FADOI Stroke Registry Investigators

134-140

12-06-2014

1517

PDF: 1187

Appendix: 563

HTML: 622
Portal vein thrombosis and Budd-Chiari syndrome as onset of polycythemia vera

Aurelio Seidita, Delia Sprini, Accursia BongiovÃ¬, Tiziana Catalano, Filippo Barbiera, Maria Accardi, Pasquale Mansueto, Antonio Carroccio

196-205

19-09-2013

1813

PDF: 1034

HTML: 1868
Results of prospective multicenter study on heart failure on Campania Internal Medicine wards: the FASHION study

Fernando Gallucci, Ilaria Ronga, Andrea Fontanella, Generoso Uomo, and the FASHION Study Group

184-190

14-06-2017

1282

PDF: 710

HTML: 450
Sex differences in adverse drug reaction and liver disease

Ombretta Para, Pietro Crispino, Nunzia Barone, Sara Macis, Laura Airasca, Paola Gnerre, Cecilia Politi

15-22

20-03-2018

1932

PDF: 823

HTML: 441
Thrombophilias: therapeutic employment of direct oral anticoagulants in venous hypercoagulable states

Federico Cacciapuoti

136-142

17-09-2020

723

PDF: 477

HTML: 292
Management of major bleeding in patients treated with direct oral anticoagulants: from experience to standardized protocols

Sara Mascia, Anna Maria Ferrari, Nicola Macarone Palmieri, Elisa Romagnoli, Chiara Catena, Serena Scarabottini, Francesca Mori, Lucio Brugioni

43-48

17-06-2020

870

PDF: 584

HTML: 142
Gender medicine: an up-date

Cecilia Politi, Tiziana Ciarambino, Flavia Franconi, Lucrezia De Feudis, Maria Carolina Mayer, Alessandra Martignoni, Ilaria Giovi, Michela Tonani, Salvatore La Carrubba, Anna Maria Moretti, Carmen Martino, Giovanni Scanelli

96-106

24-04-2013

2015

PDF: 865

HTML: 468
A dangerous adverse event in the use of dabigatran

Manuel Monti, Giovanni Maria Vincentelli, Francesco Borgognoni, Giuseppe Murdolo, Feliciano Menghini

250-251

09-11-2015

1556

PDF: 862

HTML: 253
Treatment and secondary prophylaxis of venous thromboembolism with direct oral anticoagulants in patients with severe hereditary thrombophilia

Pasquale Madonna, Anna Guida, Maria Gabriella Coppola, Paolo Tirelli, Ernesto Grasso

18-03-2021

1016

PDF: 499

HTML: 51
The management of the patient with acute pancreatitis: from evidence to clinical practice

Cristina Cenci, Tea Restuccia, Paola Gnerre, Irene Chiti, Laura Betti, Milena Micati, Claudio Tana

220-245

11-09-2017

2600

PDF: 1148

HTML: 1321
Optimal duration of anticoagulant therapy in patients with venous thromboembolism

Gualtiero Palareti

235-244

14-09-2018

1429

PDF: 1731

HTML: 257
Anticoagulation in the early phase of non-valvular atrial fibrillation-related acute ischemic stroke: where do we stand?

Luca Masotti, Elisa Grifoni, Alessandro Dei, Vieri Vannucchi, Federico Moroni, Grazia Panigada, Stefano Spolveri, Giancarlo Landini

24-31

03-01-2019

1325

PDF: 732

HTML: 70
Management of chronic obstructive pulmonary disease: criteria for an appropriate hospital discharge

Marco Candela, Ruggero Pastorelli, Antonio Sacchetta, Mauro Campanini, Leonardo M. Fabbri, Carlo Nozzoli

218-230

19-09-2013

1382

PDF: 1011

HTML: 854
The management of heart failure: a FADOI survey in the setting of Internal Medicine Units

Fernando Gallucci

16-02-2023

1655

PDF: 486

HTML: 13
How artificial intelligence during the pandemic modified the role of a biomarker as d-dimer

Pierpaolo Di Micco, Francesca Futura Bernardi, Giovanni Maria Fusco, Alessandro Perrella

20-11-2023

809

PDF: 252

HTML: 27
Equivalent/generic drugs use. To whom? When? How?

Andrea Fontanella

77-79

08-05-2014

1006

PDF: 752

HTML: 236
The management of the patient with non-variceal upper gastrointestinal bleeding: from evidence to clinical practice

Maddalena Zippi, Mariella Frualdo, Luciano Mucci, Marta Zanon, Chiara Marzano, Claudio Cassieri, Paola Gnerre, Pietro Crispino

246-252

27-12-2016

1372

PDF: 911

HTML: 280
An unusual cause of massive hemoptysis

Silvia Maestroni, Martino Cellerini, Antonio Brucato

71-74

01-07-2016

1281

PDF: 820

HTML: 378

1 - 34 of 34 items

© PAGEPress 2008-2024 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy